MedTech News
OrthAlign Receives FDA 510(k) Clearance for Lantern® Hip
IRVINE, Calif., Oct. 3, 2024 /PRNewswire/ — OrthAlign, Inc., a privately held medical device company, announces FDA 510(k) clearance of their Lantern Hip handheld technology for direct anterior total hip arthroplasty with the patient in the supine position. Lantern Hip is the latest addition to the Lantern platform, joining existing applications for total knee, revision knee, and partial knee arthroplasty.
OrganOx metra system approved for liver transplantation in Canada
A 2025 commercial launch is planned to expand access to this platform technology.
Elucid receives FDA clearance for PlaqueIQ image analysis software
The company says this is the first and only software validated on ground-truth histology, the gold standard for plaque characterisation according to the company.
MIT engineers create a chip-based tractor beam for biological particles
The tiny device uses a tightly focused beam of light to capture and manipulate cells.
Eyenovia begins manufacturing next-gen drug delivery system
Eyenovia (Nasdaq:EYEN) announced that it began manufacturing batches of its Mydcombi product for its next-generation delivery platform.
SetPoint Medical gets FDA IDE to study neurostimulation for MS
SetPoint Medical today announced FDA Investigational Device Exemption approval to study its proprietary neuroimmune modulation platform for people with relapsing-remitting multiple sclerosis.
AtriCure wins CE mark for EnCompass clamp device
AtriCure (Nasdaq: ATRC)+
announced that it received CE mark for the EnCompass clamp for cardiac tissue ablation procedures.
BioIntellisense wins FDA nod for BioButton multi-patient wearable monitor
BioIntelliSense announced today that it received FDA clearance for its rechargeable BioButton multi-patient wearable and BioDashboard system.